These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20852005)

  • 41. Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects.
    Sarapa N; Gussak I; Vajdic B; George S; Hadzievski L; Francom SF; Kowey P
    J Electrocardiol; 2009; 42(4):358-66. PubMed ID: 19362316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.
    Sarapa N; Nickens DJ; Raber SR; Reynolds RR; Amantea MA
    Clin Pharmacol Ther; 2008 Jan; 83(1):153-9. PubMed ID: 17581594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Timing of pre-dose baseline electrocardiograms in clinical trials: increased sampling over a prolonged baseline period worsens variance of QTc.
    Mason JW
    J Electrocardiol; 2014; 47(5):716-20. PubMed ID: 25060126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers.
    Radziszewski W; Lai E; Lazarus Shipitofsky N; Stroh M; Dishy V; Han L; Lewis W; Johnson-Levonas AO; Lutz R; Wagner J
    Am J Ther; 2010; 17(1):8-16. PubMed ID: 20027105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing QT interval variability of semiautomated and high-precision ECG methodologies in seven thorough QT studies-implications for the power of studies intended for definitive evaluation of a drug's QT effect.
    Meiser K; Jordaan P; Latypova S; Darpo B
    Ann Noninvasive Electrocardiol; 2017 Jan; 22(1):. PubMed ID: 27995684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statistical issues of QT prolongation assessment based on linear concentration modeling.
    Tsong Y; Shen M; Zhong J; Zhang J
    J Biopharm Stat; 2008; 18(3):564-84. PubMed ID: 18470764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Baseline correction in parallel thorough QT studies.
    Zhang J; Dang Q; Malik M
    Drug Saf; 2013 Jun; 36(6):441-53. PubMed ID: 23620166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic decrements in QTc between the first and second day of contiguous daily ECG recordings under controlled conditions.
    Beasley CM; Benson C; Xia JQ; Young SS; Haber H; Mitchell MI; Loghin C
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1116-27. PubMed ID: 21535038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Four-Way Crossover Phase 1 Thorough QT Study to Assess Cardiac Safety of Domperidone and Consideration for Design and Conduct of QT/QTc Study in China.
    Wang F; Nie J; Yang L; Yang Z; Xu L; Wang L; Liao H; Li M; Wang P; Li G; Li H
    Clin Pharmacol Drug Dev; 2022 Jun; 11(6):734-743. PubMed ID: 35157791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
    Bloomfield DM; Krishna R; Hreniuk D; Hickey L; Ghosh K; Bergman AJ; Miller J; Gutierrez MJ; Stoltz R; Gottesdiener KM; Herman GA; Wagner JA
    J Clin Pharmacol; 2009 Aug; 49(8):937-46. PubMed ID: 19602719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
    Corović N; Duraković Z; Misigoj-Duraković M
    Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oritavancin, a new lipoglycopeptide antibiotic: results from a thorough QT study.
    Darpo B; Lee SK; Moon TE; Sills N; Mason JW
    J Clin Pharmacol; 2010 Aug; 50(8):895-903. PubMed ID: 20484618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic comparisons of electrocardiographic morphology increase the precision of QT interval measurement.
    Hnatkova K; Smetana P; Toman O; Bauer A; Schmidt G; Malik M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):119-30. PubMed ID: 19140922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects.
    Démolis JL; Kubitza D; Tennezé L; Funck-Brentano C
    Clin Pharmacol Ther; 2000 Dec; 68(6):658-66. PubMed ID: 11180026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Near-thorough QT study as part of a first-in-man study.
    Malik M; Hnatkova K; Ford J; Madge D
    J Clin Pharmacol; 2008 Oct; 48(10):1146-57. PubMed ID: 18757785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences between QT and RR intervals in digital and digitized paper electrocardiograms: contribution of the printer, scanner, and digitization process.
    Hingorani P; Karnad DR; Panicker GK; Deshmukh S; Kothari S; Narula D
    J Electrocardiol; 2008; 41(5):370-5. PubMed ID: 18482732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysis.
    Agin MA; Aronstein WS; Ferber G; Geraldes MC; Locke C; Sager P
    J Biopharm Stat; 2008; 18(3):408-26. PubMed ID: 18470753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.